companydata.dkNovo Nordisk Denmark A/S: Financial statements 2019
CVR: 38180045
Novo Nordisk Denmark A/S (CVR 38180045) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 363,935,809 and a net result of DKK 5,251,810 compared with DKK 4,213,051 the year before. That is an increase of 6.4% compared with the year before. The profit margin was 1.4%. Equity amounted to DKK 15,343,476. The solvency ratio was 10.3%. The company had 65 employees in the financial year.
- Revenue
- 363,935,809 kr.
- Gross Profit
- 134,886,410 kr.
- Profit/Loss
- 5,251,810 kr.
- Equity
- 15,343,476 kr.
- Total Assets
- 149,607,751 kr.
- Employees
- 65
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 363.9 mio. | 134.9 mio. | 5.3 mio. | 15.3 mio. | 65 |
| 2018 | 341.9 mio. | 119.2 mio. | 4.2 mio. | 10.1 mio. | 69 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
As of December 1, 2019, Kasper Bødker Mejlvang is registered as director of Novo Nordisk Denmark A/S.
As of November 30, 2019, Morten Berger Engelund has stepped down as director of Novo Nordisk Denmark A/S.
As of October 1, 2019, Mads Veggerby Lausten has joined the board of directors of Novo Nordisk Denmark A/S.
As of October 1, 2019, Matt Joseph Regan has joined the board of directors of Novo Nordisk Denmark A/S.
As of October 1, 2019, Karsten Munk Knudsen has left the board of directors of Novo Nordisk Denmark A/S.
On October 1, 2019, the company changed its name from Novo Nordisk Region Europe Pharmaceuticals A/S to Novo Nordisk Denmark A/S.
As of September 30, 2019, Matt Joseph Regan has left the board of directors of Novo Nordisk Denmark A/S.
Novo Nordisk Denmark A/S has published its annual report for 2018. Revenue came to DKK 341,939,236, and the net result was DKK 4,213,051.
About Novo Nordisk Denmark A/S
Novo Nordisk Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Novo Nordisk Region Europe Pharmaceuticals A/S. The management consists of Mads Wilhelm Øckenholt Larsen. The company is owned by NOVO NORDISK REGION EUROPE A/S. The company has 81 employees. In 2025, the company reported revenue of DKK 2,504,841,000 and a net result of DKK 118,803,000 compared with DKK 86,129,000 the year before. Equity amounted to DKK 134,570,000.